ABUJA – The House of Representatives has called on its relevant committees to work with the Federal Ministry of Health and the National Health Insurance Authority (NHIA) to conduct a comprehensive review of the current price list for medicines and healthcare services under the National Health Insurance Scheme (NHIS).
This decision followed a motion of urgent public importance moved by Hon. Paul Nnamchi, Member representing Enugu East/Isi-Uzo Federal Constituency, and House Leader, Julius Ihonvbere, during Thursday’s plenary.
The lawmakers highlighted the need for an updated price list, considering the severe economic challenges facing the country.
Hon. Nnamchi emphasized the importance of affordable healthcare access, noting that the NHIS was designed to serve as a lifeline for millions of Nigerians, especially those from vulnerable communities. However, with the current economic downturn, the scheme’s pricing structure has become outdated and inaccessible for many citizens.
Advertisement
“The Nigerian nation is presently grappling with economic hardship, inflationary pressures, and rising costs of living, which have had a profound impact on the affordability and accessibility of healthcare services and medications for many of our citizens, particularly the vulnerable and marginalised segments of society,” Nnamchi stated.
He pointed out that the last review of the NHIS price list occurred in 2021 when the exchange rate was between N400–N420 to $1, whereas today, the official rate is N1,594 to $1. This drastic shift has made it increasingly difficult for low-income patients to afford essential medications, exacerbating the country’s healthcare challenges.
The Lawmaker stressed the urgency of the situation, warning that without immediate action, the loss of lives among poor Nigerians will continue to rise.
Following the debate, the House unanimously adopted the motion and mandated its Committees on Finance, Health Institutions, Healthcare Services, and Specialist Health Services to collaborate with the Federal Ministry of Health, the NHIA, and other stakeholders.
They are to ensure a comprehensive review of the NHIA’s price list within two weeks to align with current market realities.
